Global and United States Acute Intermittent Porphyria Market Report & Forecast 2023-2028

Report ID: 1844075 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Acute Intermittent Porphyria Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Acute Intermittent Porphyria Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Acute Intermittent Porphyria Market Size for the Year 2017-2028
        1.2.2 Global Acute Intermittent Porphyria Market Size for the Year 2017-2028
    1.3 Acute Intermittent Porphyria Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Acute Intermittent Porphyria in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Acute Intermittent Porphyria Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Acute Intermittent Porphyria Market Dynamics
        1.4.1 Acute Intermittent Porphyria Industry Trends
        1.4.2 Acute Intermittent Porphyria Market Drivers
        1.4.3 Acute Intermittent Porphyria Market Challenges
        1.4.4 Acute Intermittent Porphyria Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Acute Intermittent Porphyria by Type
    2.1 Acute Intermittent Porphyria Market Segment by Type
        2.1.1 Gonadotropin-Releasing Hormone Analogues
        2.1.2 Prophylactic Hematin Infusions
    2.2 Global Acute Intermittent Porphyria Market Size by Type (2017, 2022 & 2028)
    2.3 Global Acute Intermittent Porphyria Market Size by Type (2017-2028)
    2.4 United States Acute Intermittent Porphyria Market Size by Type (2017, 2022 & 2028)
    2.5 United States Acute Intermittent Porphyria Market Size by Type (2017-2028)
3 Acute Intermittent Porphyria by Application
    3.1 Acute Intermittent Porphyria Market Segment by Application
        3.1.1 Hospitals & Clinics
        3.1.2 Research Centers
    3.2 Global Acute Intermittent Porphyria Market Size by Application (2017, 2022 & 2028)
    3.3 Global Acute Intermittent Porphyria Market Size by Application (2017-2028)
    3.4 United States Acute Intermittent Porphyria Market Size by Application (2017, 2022 & 2028)
    3.5 United States Acute Intermittent Porphyria Market Size by Application (2017-2028)
4 Global Acute Intermittent Porphyria Competitor Landscape by Company
    4.1 Global Acute Intermittent Porphyria Market Size by Company
        4.1.1 Top Global Acute Intermittent Porphyria Companies Ranked by Revenue (2021)
        4.1.2 Global Acute Intermittent Porphyria Revenue by Player (2017-2022)
    4.2 Global Acute Intermittent Porphyria Concentration Ratio (CR)
        4.2.1 Acute Intermittent Porphyria Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Acute Intermittent Porphyria in 2021
        4.2.3 Global Acute Intermittent Porphyria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Acute Intermittent Porphyria Headquarters, Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Acute Intermittent Porphyria Headquarters and Area Served
        4.3.2 Global Acute Intermittent Porphyria Companies Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Acute Intermittent Porphyria Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Acute Intermittent Porphyria Market Size by Company
        4.5.1 Top Acute Intermittent Porphyria Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Acute Intermittent Porphyria Revenue by Players (2020, 2021 & 2022)
5 Global Acute Intermittent Porphyria Market Size by Region
    5.1 Global Acute Intermittent Porphyria Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Acute Intermittent Porphyria Market Size by Region (2017-2028)
        5.2.1 Global Acute Intermittent Porphyria Market Size by Region: 2017-2022
        5.2.2 Global Acute Intermittent Porphyria Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Acute Intermittent Porphyria Market Size YoY Growth 2017-2028
        6.1.2 North America Acute Intermittent Porphyria Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Acute Intermittent Porphyria Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Acute Intermittent Porphyria Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Acute Intermittent Porphyria Market Size YoY Growth 2017-2028
        6.3.2 Europe Acute Intermittent Porphyria Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Acute Intermittent Porphyria Market Size YoY Growth 2017-2028
        6.4.2 Latin America Acute Intermittent Porphyria Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Acute Intermittent Porphyria Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Acute Intermittent Porphyria Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Dahaner
        7.1.1 Dahaner Company Details
        7.1.2 Dahaner Business Overview
        7.1.3 Dahaner Acute Intermittent Porphyria Introduction
        7.1.4 Dahaner Revenue in Acute Intermittent Porphyria Business (2017-2022)
        7.1.5 Dahaner Recent Development
    7.2 Roche
        7.2.1 Roche Company Details
        7.2.2 Roche Business Overview
        7.2.3 Roche Acute Intermittent Porphyria Introduction
        7.2.4 Roche Revenue in Acute Intermittent Porphyria Business (2017-2022)
        7.2.5 Roche Recent Development
    7.3 Bio-Rad Laboratories
        7.3.1 Bio-Rad Laboratories Company Details
        7.3.2 Bio-Rad Laboratories Business Overview
        7.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Introduction
        7.3.4 Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2017-2022)
        7.3.5 Bio-Rad Laboratories Recent Development
    7.4 Siemens
        7.4.1 Siemens Company Details
        7.4.2 Siemens Business Overview
        7.4.3 Siemens Acute Intermittent Porphyria Introduction
        7.4.4 Siemens Revenue in Acute Intermittent Porphyria Business (2017-2022)
        7.4.5 Siemens Recent Development
    7.5 ARKRAY
        7.5.1 ARKRAY Company Details
        7.5.2 ARKRAY Business Overview
        7.5.3 ARKRAY Acute Intermittent Porphyria Introduction
        7.5.4 ARKRAY Revenue in Acute Intermittent Porphyria Business (2017-2022)
        7.5.5 ARKRAY Recent Development
    7.6 Sysmex Corporation
        7.6.1 Sysmex Corporation Company Details
        7.6.2 Sysmex Corporation Business Overview
        7.6.3 Sysmex Corporation Acute Intermittent Porphyria Introduction
        7.6.4 Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2017-2022)
        7.6.5 Sysmex Corporation Recent Development
    7.7 ACON Laboratories
        7.7.1 ACON Laboratories Company Details
        7.7.2 ACON Laboratories Business Overview
        7.7.3 ACON Laboratories Acute Intermittent Porphyria Introduction
        7.7.4 ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2017-2022)
        7.7.5 ACON Laboratories Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Acute Intermittent Porphyria Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Acute Intermittent Porphyria Market Trends
    Table 3. Acute Intermittent Porphyria Market Drivers
    Table 4. Acute Intermittent Porphyria Market Challenges
    Table 5. Acute Intermittent Porphyria Market Restraints
    Table 6. Global Acute Intermittent Porphyria Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Acute Intermittent Porphyria Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Acute Intermittent Porphyria Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Acute Intermittent Porphyria Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Acute Intermittent Porphyria Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Acute Intermittent Porphyria Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Acute Intermittent Porphyria Revenue Share by Player, 2017-2022
    Table 13. Global Acute Intermittent Porphyria Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Acute Intermittent Porphyria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Intermittent Porphyria as of 2021)
    Table 15. Top Players of Acute Intermittent Porphyria in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Acute Intermittent Porphyria Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Acute Intermittent Porphyria Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Acute Intermittent Porphyria Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Acute Intermittent Porphyria Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Acute Intermittent Porphyria Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Acute Intermittent Porphyria Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Acute Intermittent Porphyria Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Acute Intermittent Porphyria Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Acute Intermittent Porphyria Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Acute Intermittent Porphyria Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Acute Intermittent Porphyria Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Acute Intermittent Porphyria Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Dahaner Company Details
    Table 31. Dahaner Business Overview
    Table 32. Dahaner Acute Intermittent Porphyria Product
    Table 33. Dahaner Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million)
    Table 34. Dahaner Recent Development
    Table 35. Roche Company Details
    Table 36. Roche Business Overview
    Table 37. Roche Acute Intermittent Porphyria Product
    Table 38. Roche Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million)
    Table 39. Roche Recent Development
    Table 40. Bio-Rad Laboratories Company Details
    Table 41. Bio-Rad Laboratories Business Overview
    Table 42. Bio-Rad Laboratories Acute Intermittent Porphyria Product
    Table 43. Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million)
    Table 44. Bio-Rad Laboratories Recent Development
    Table 45. Siemens Company Details
    Table 46. Siemens Business Overview
    Table 47. Siemens Acute Intermittent Porphyria Product
    Table 48. Siemens Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million)
    Table 49. Siemens Recent Development
    Table 50. ARKRAY Company Details
    Table 51. ARKRAY Business Overview
    Table 52. ARKRAY Acute Intermittent Porphyria Product
    Table 53. ARKRAY Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million)
    Table 54. ARKRAY Recent Development
    Table 55. Sysmex Corporation Company Details
    Table 56. Sysmex Corporation Business Overview
    Table 57. Sysmex Corporation Acute Intermittent Porphyria Product
    Table 58. Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million)
    Table 59. Sysmex Corporation Recent Development
    Table 60. ACON Laboratories Company Details
    Table 61. ACON Laboratories Business Overview
    Table 62. ACON Laboratories Acute Intermittent Porphyria Product
    Table 63. ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2017-2022) & (US$ Million)
    Table 64. ACON Laboratories Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acute Intermittent Porphyria Product Picture
    Figure 2. Global Acute Intermittent Porphyria Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Acute Intermittent Porphyria Market Size 2017-2028 (US$ Million)
    Figure 4. United States Acute Intermittent Porphyria Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Acute Intermittent Porphyria Market Size 2017-2028 (US$ Million)
    Figure 6. United States Acute Intermittent Porphyria Market Share in Global 2017-2028
    Figure 7. Acute Intermittent Porphyria Report Years Considered
    Figure 8. Product Picture of Gonadotropin-Releasing Hormone Analogues
    Figure 9. Product Picture of Prophylactic Hematin Infusions
    Figure 10. Global Acute Intermittent Porphyria Market Share by Type in 2022 & 2028
    Figure 11. Global Acute Intermittent Porphyria Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Acute Intermittent Porphyria Market Share by Type (2017-2028)
    Figure 13. United States Acute Intermittent Porphyria Market Share by Type in 2022 & 2028
    Figure 14. United States Acute Intermittent Porphyria Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Acute Intermittent Porphyria Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals & Clinics
    Figure 17. Product Picture of Research Centers
    Figure 18. Global Acute Intermittent Porphyria Market Share by Application in 2022 & 2028
    Figure 19. Global Acute Intermittent Porphyria Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Acute Intermittent Porphyria Market Share by Application (2017-2028)
    Figure 21. United States Acute Intermittent Porphyria Market Share by Application in 2022 & 2028
    Figure 22. United States Acute Intermittent Porphyria Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Acute Intermittent Porphyria Market Share by Application (2017-2028)
    Figure 24. North America Acute Intermittent Porphyria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. U.S. Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Acute Intermittent Porphyria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Acute Intermittent Porphyria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Taiwan Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Philippines Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Acute Intermittent Porphyria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Acute Intermittent Porphyria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.A.E Acute Intermittent Porphyria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Dahaner Revenue Growth Rate in Acute Intermittent Porphyria Business (2017-2022)
    Figure 53. Roche Revenue Growth Rate in Acute Intermittent Porphyria Business (2017-2022)
    Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2017-2022)
    Figure 55. Siemens Revenue Growth Rate in Acute Intermittent Porphyria Business (2017-2022)
    Figure 56. ARKRAY Revenue Growth Rate in Acute Intermittent Porphyria Business (2017-2022)
    Figure 57. Sysmex Corporation Revenue Growth Rate in Acute Intermittent Porphyria Business (2017-2022)
    Figure 58. ACON Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Dahaner
Roche
Bio-Rad Laboratories
Siemens
ARKRAY
Sysmex Corporation
ACON Laboratories
Frequently Asked Questions
Acute Intermittent Porphyria report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Intermittent Porphyria report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Intermittent Porphyria report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Acute Pancreatitis

Acute Pancreatitis market is segmented by region (country), players, by Type and by Application.  ... Read More

ADHD Therapeutics

ADHD Therapeutics market is segmented by region (country), players, by Type and by Application. P ... Read More